JAK1 as a prognostic marker and its correlation with immune infiltrates in breast cancer

Clinical trials testing Janus kinase-1 (JAK1) inhibitors in cancers are under way. Whether the JAK1 mRNA levels in breast tumors correlates with outcome has not been evaluated. JAK1 expression was analyzed via the Oncomine database and Tumor IMmune Estimation Resource site. Tumor tissues from 57 bre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Bo, Lai, Jianguo, Dai, Danian, Chen, Rong, Li, Xuan, Liao, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932910/
https://www.ncbi.nlm.nih.gov/pubmed/31790361
http://dx.doi.org/10.18632/aging.102514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932910/
https://www.ncbi.nlm.nih.gov/pubmed/31790361
http://dx.doi.org/10.18632/aging.102514

Ejemplares similares